Federal Emergency Grant Opportunities

A listing of emergency federal grant opportunities to help nonprofits recover and respond to the COVID-19 crisis

Billions of CARES Act dollars have been allocated to federal funding agencies to be awarded to nonprofits in the form of emergency grants. We will add new emergency federal grant opportunities as they are announced, so visit this page frequently for updates.

Complete Guide to Emergency Federal Grant Seeking During Crisis

Visit our complete federal grant seeking resource center. We've compiled tips and resources to help your organization find and successfully secure emergency federal grant funding.

Our team is watching closely for the release of new emergency federal grant opportunities. Sign up to receive our emergency federal grant alert, and we will alert you to new additions each week as they are announced.

Department of Education

Higher Education Emergency Relief Funds

Institutions of higher education are eligible to receive formula-based funds to cover expenses related to the disruption of campus operations due to COVID-19. Institutions must sign and return a Certificate of Funding and Agreement through Grants.gov to receive immediate access to the funds.

Deadline: 9/30/2020

Department of Health and Human Services

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 and Coronavirus Disease 2019 (R21 Clinical Trial Not Allowed)

The purpose of the funding is to provide an expedited mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). The National Institute of Allergy and Infectious Disease is issuing the opportunity in response to the declared public health emergency. Applications are accepted on a rolling basis with an expedited review and award basis.

Deadline: 4/29/2021

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 and Coronavirus Disease 2019 (R01 Clinical Trial Not Allowed)

The purpose of the funding is to provide an expedited mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). The National Institute of Allergy and Infectious Disease is issuing the opportunity in response to the declared public health emergency. Applications are accepted on a rolling basis with an expedited review and award basis.

Deadline: 4/29/2021

NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional)

This opportunity solicits applications responsive only to the COVID-19 public health emergency through support of the CARES Act. The award program supports individual scientists or groups of scientists with projects demonstrating a compelling potential to produce a major impact on COVID-19 prevention, preparation, or response. Any relevant area of research is encouraged, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics.

Deadline: 9/30/2020

Community Interventions to Address the Consequences of the COVID-19 Pandemic Among Health Disparity and Vulnerable Populations (R01 - Clinical Trial Optional)

This funding opportunity announcement invites applications to implement and evaluate community interventions testing for 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, behavioral, and socioeconomic consequences of the pandemic on the health of these groups. Eligible applicants include nonprofits; institutions of higher education; city, county, state governments; school districts, and small businesses.

Deadline: 12/1/2020

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)

This funding opportunity announcement aims to support research to strengthen the healthcare response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and future public health emergencies, including pandemics. While research related to the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this funding opportunity is to focus on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations.

Deadline: 3/2/2021

Emergency Awards: RADx-rad: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed)

The goal of this initiative is to solicit applications for the development of novel, non-traditional approaches to identify the current SARS-CoV-2 virus or other biomarkers of the disease for use in outbreaks of COVID-19, as well as for future pandemics resulting from new and emerging viruses.

Deadline: 9/18/2020

Emergency Awards RADx-rad Wastewater Detection of SARS-COV-2 (U01 - Clinical Trials Not Allowed)

The Wastewater Detection FOA will support wastewater-based testing surveillance which can provide detailed mapping of the extent and spread of COVID-19. The purpose of the initiative is to solicit cooperative agreements both for field studies and for technology research and development projects capitalizing on partnerships with small business entities in the field of wastewater-based testing, to address topics such as investigation and demonstration of specific approaches aiming to inform and optimize sample collection; implementation and development of optimized approaches to extrapolate estimation of population-level data within the community; development of optimized intervention strategies; and incorporation of computational, statistical, and mathematical models to facilitate early detection of hotspots of virus spread.

Deadline: 9/15/2020

Emergency Awards RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed)

This emergency FOA provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostic-Radical (RADx-rad) initiative. The FOA seeks to fund a single cooperative agreement for a Data Coordination Center (DCC) to serve as a communication center and data hub for RADx-rad awardees.

Deadline: 9/30/2020

Emergency Awards: Automatic Detection and Tracing of SARS-COV-2 (U01 Clinical Trial Not Allowed)

The goal of the RFA is to solicit proposals for the development of novel, non-traditional approaches to identify the current SARS-CoV-2 virus or other markers of the COVID-19 disease that can be used in future outbreaks of COVID-19 and that could be applicable to other, as yet unknown, viruses. Support will be provided for early stage development of an innovative platform that integrates aptamer biosensing with touchscreen or other digital devices to achieve real-time detection and tracing of SARS-CoV-2

Deadline: 9/15/2020

Emergency Awards: RADx-rad Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)

Applications are invited that translate a combination of digital surveillance modalities into platforms that can assist the professional staff of high-risk facilities in making clinically meaningful care recommendations for patients at risk of COVID-19 or other respiratory viruses. Projects proposed may use strategies that incorporate ideas and approaches from multiple disciplines, as appropriate.

Deadline: 9/30/2020

Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kids) (R61/R33 Clinical Trial Option)

This FOA seeks to support innovative research to develop novel, new or unique and non-traditional approaches (e.g. diagnostic and prognostic biomarkers and/or biosignatures) to identify and characterize the spectrum of SARS CoV-2 associated illness, including the multisystem inflammatory syndrome in children (MIS-C) and, through a prognostic algorithm, predict the longitudinal risk of disease severity after a child is exposed to and may be infected with SARS-CoV-2 to properly tailor his or her management and optimize health outcomes.

Deadline: 9/30/2020

Emergency Awards RADx-rad: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)

The goal of this RFA is to solicit Fast-Track STTR applications to advance development of novel, non-traditional, safe and effective biosensing and detection approaches to identify the current SARS-CoV-2 virus or other biomarkers of the COVID-19 disease for use in outbreaks of COVID-19, as well as for use in future pandemics resulting from unknown viruses.

Deadline: 9/18/2020

Emergency Awards RADx-rad: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)

The goal of this RFA is to solicit Direct to Phase II SBIR applications to advance development of novel, non-traditional, safe and effective biosensing and detection approaches to identify the current SARS-CoV-2 virus or other biomarkers of the COVID-19 disease for use in outbreaks of COVID-19, as well as for use in future pandemics resulting from unknown viruses.

Deadline: 9/18/2020

Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)

This FOA seeks to use developed technologies for single vesicle or exosome isolation and analysis and reposition these technologies for the detection of SARS-CoV-2.

Deadline: 9/18/2020

Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional)

The goal of this FOA is to solicit applications to enhance the utility of chemosensory testing as a COVID-19 screening tool by using objective tests to examine the onset and prognostic value of chemosensory loss and to encourage the development and/or deployment of home-based and on-site chemosensory tests.

Deadline: 9/15/2020

Federal Communications Commission

COVID-19 Telehealth Program

Grants of up to $1 million will be awarded to health care providers to fund telecommunications services, information services, and devices necessary to provide critical connected care services. $200 million is available and will be distributed to eligible applicants until the funds are fully expended.

Deadline: 9/30/2020

Institute of Museum and Library Services

New Grant Flexibilities

$30 million of federally appropriated funding provided to IMLS (Institute for Museum and Library Services) will be distributed to State Library Administrative Agencies (SLAAs) Funds can be used to expand digital network access, purchase internet accessible devices, and provide technical support services to address digital inclusivity. IMLS will announce additional measures for museums and libraries as federal allocations allow. (Note, per IMLS, museums include, but are not limited to aquariums, arboretums, art museums, botanical gardens, children's museums, history museums, historic sites, natural history museums, nature centers, planetariums, science centers, and zoos.

Deadlines: Varies based on state SLAA guidelines

National Aeronautics and Space Administration

2020 NASA Teams Engaging Affiliated Museums and Informal Institutions Remote Opportunity Rapid Response (TEAM II RORR)

NASA’s Office of STEM Engagement, collaborating closely with the Mission Directorates, and also in cooperation with NASA Headquarters’ Office of Communications and Office of Diversity and Equal Opportunity, solicits proposals led by Informal Education Institutions (IEIs) to provide inquiry- or experiential-based educational opportunities with direct alignment to major NASA missions for students and the public.

This one-time Teams Engaging Affiliated Museums and Informal Institutions (TEAM II) Remote Opportunity Rapid Response (RORR) competitive solicitation will provide financial support in the range of $100K-$175K for up to one year for Informal Education Institutions to amplify or create an innovative remote or distance-learning program, opportunity, or platform/project to reach K-12 students using relevant NASA content during the 2020-2021 school year and/or in summer 2021 and continuing beyond.

Deadline: 8/13/2020

National Science Foundation

Rapid Response Research

The National Science Foundation is accepting proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge. The Foundation encourages the research community to respond to the challenge through existing funding opportunities and invites researchers to use the Rapid Response Research funding mechanism to submit proposals for up to $200,000 and up to one year in duration.

Deadline: N/A

Substance Abuse and Mental Health Services Administration

Discretionary Grant Flexibility

The Substance Abuse and Mental Health Services Administration is allowing flexibility for grant recipients affected by the loss of operational capacity and increased costs due to COVID-19. Grantees have the flexibility to re-budget up to 25% (max of $250,000) of their current budget as long as the activities are allowable under the contract. Re-budgeting beyond this amount requires grantees to submit a post-award amendment request.

Deadline: N/A

Learn how Grants Plus can assist you to pursue emergency federal funds and other grant opportunities.